Abstract
Background
Ultrafine particles (UFP) may contribute to the cardiovascular effects of exposure to particulate air pollution, partly because of their relatively efficient alveolar deposition and potential to enter the pulmonary vascular space.
Objectives
This study tested the hypothesis that inhalation of elemental carbon UFP alters systemic vascular function.
Methods
Sixteen healthy subjects (mean age, 26.9 ± 6.5 years) inhaled air or 50 μg/m3 elemental carbon UFP by mouthpiece for 2 hr, while exercising intermittently. Measurements at preexposure baseline, 0 hr (immediately after exposure), 3.5 hr, 21 hr, and 45 hr included vital signs, venous occlusion plethysmography and reactive hyperemia of the forearm, and venous plasma nitrate and nitrite levels.
Results
Peak forearm blood flow after ischemia increased 3.5 hr after exposure to air but not UFP (change from preexposure baseline, air: 9.31 ± 3.41; UFP: 1.09 ± 2.55 mL/min/100 mL; t-test, p = 0.03). Blood pressure did not change, so minimal resistance after ischemia (mean blood pressure divided by forearm blood flow) decreased with air, but not UFP [change from preexposure baseline, air: −0.48 ± 0.21; UFP: 0.07 ± 0.19 mmHg/mL/min; analysis of variance (ANOVA), p = 0.024]. There was no UFP effect on pre-ischemia forearm blood flow or resistance, or on total forearm blood flow after ischemia. Venous nitrate levels were significantly lower after exposure to carbon UFP compared with air (ANOVA, p = 0.038). There were no differences in venous nitrite levels.
Conclusions
Inhalation of 50 μg/m3 carbon UFP during intermittent exercise impairs peak forearm blood flow during reactive hyperemia in healthy human subjects.
Keywords: air pollution, nitric oxide, particulate matter, reactive hyperemia, vascular
Cardiovascular morbidity and mortality are associated with exposure to air pollution particles (Bremner et al. 1999; Burnett et al. 1999; Peters et al. 2000, 2001; Pope et al. 2004). Data analyzed from 1.2 million adults in the United States from 1982–1998 linked 10-μg/m3 elevations in particulate matter (PM) < 10 μm in diameter (PM10) with a 6% increase in deaths from cardiopulmonary disease (Pope et al. 2002). Among > 65,000 women followed in the Women’s Health Initiative study (Miller et al. 2007), a 10-μg/m3 increase in PM < 2.5 μm (PM=2.5) was associated with a 24% increased risk for a cardiovascular event, and a 76% increase in the risk of death from cardiovascular disease. Exposure to PM has been associated with increased risk for myocardial infarction (Peters et al. 2001, 2004), cardiac arrhythmias (Peters et al. 2000), increases in blood pressure (Ibald-Mulli et al. 2001), reductions in heart rate variability (Gold et al. 2000; Pope et al. 1999), increased blood markers of inflammation and coagulation (Rückerl et al. 2006), and more rapid progression of atherosclerosis (Künzli et al. 2005). Despite convincing epidemiologic evidence linking particle exposure and cardiovascular disease, the relevant particle characteristics and mechanisms remain poorly defined.
Ultrafine particles (UFP) (diameter < 100 nm) have been hypothesized as contributors to cardiovascular effects of PM. High concentrations of UFP are found on and near major highways (Kittelson et al. 2004), where they may contribute to the increased risk of myocardial infarction associated with exposure to traffic (Peters et al. 2004). Their characteristics suggest that UFP may contribute to the cardiovascular effects of PM. Compared with fine particles at similar mass concentrations, UFP have a higher number concentration and surface area (Oberdörster et al. 1995), enhanced oxidant capacity (Brown et al. 2001; Li et al. 2003), greater inflammatory potential (Oberdörster et al. 1995), and higher pulmonary deposition efficiency (Chalupa et al. 2004; Daigle et al. 2003). They are also more likely to penetrate epithelium and enter the pulmonary interstitium and vascular space (Stearns et al. 1994).
We have previously reported that exposure to 50 μg/m3 UFP caused a significant decrease in the pulmonary diffusion capacity for carbon monoxide 21 hr after exposure (Pietropaoli et al. 2004b), as well as changes in blood leukocyte expression of surface adhesion molecules (Frampton et al. 2006). These findings together suggest that inhalation of carbon UFP caused transient reductions in the pulmonary capillary blood volume, providing indirect evidence for effects of UFP on pulmonary endothelial function.
In this study, we describe the effects of inhaled UFP on a measure of systemic vascular function that is associated with coronary artery disease, forearm venous plethysmography, and reactive hyperemia (RH). We hypothesized that inhalation of elemental carbon UFP impairs RH in healthy nonsmokers. Plasma concentrations of nitrite and nitrate, products of nitric oxide metabolism, were measured to determine whether impairment in vasorelaxation was accompanied by alterations in NO metabolism. Some data from this study have been presented previously in abstract form (Pietropaoli et al. 2004a).
Materials and Methods
Subjects
The study was approved by the Research Subjects Review Board at the University of Rochester, and subjects provided written informed consent. We studied 16 healthy never-smokers (eight male and eight female) 18–40 years of age. Subjects were required to have no history of pulmonary or cardiovascular disease, normal spirometry, a normal electrocardiogram, and a negative urine pregnancy test (females). Subjects were instructed to exclude anti-inflammatory drugs for the duration of the study and to exclude caffeine, large fatty meals, and vigorous exercise during and 24 hr before study days. Subjects were not studied within 6 weeks of a respiratory infection.
Study design
The study used a double-blinded, randomized (blocked by order of presentation and sex), crossover design.
Subjects underwent a 2-hr mouthpiece exposure to either filtered air or carbon UFP, with four 15-min exercise periods on a bicycle ergometer (target minute ventilation 20 L/min/m2 body surface area). A 10-min break off the mouthpiece was taken after 1 hr of exposure. Measurements (vital signs, RH, and phlebotomy) were repeated immediately (0 hr), 3.5 hr, 21 hr, and 45 hr after exposure. Exposures were separated by at least 3 weeks.
Exposure system
Exposures were undertaken within an environmental chamber, using a mouthpiece exposure system. Briefly, the design was a one-pass, dynamic-flow exposure system. The particles [count median diameter ∼25 nm; geometric standard deviation (GSD) ∼1.6] were generated in an argon atmosphere using an electric spark discharge between two graphite electrodes, in a commercial generator (Palas Co., Karlsruhe, Germany) that had been modified to prevent any off-gassing of organic materials from within the generator (McDonald et al. 2001). This produced particles consisting of > 95% elemental carbon, without metals. The particles were then deionized and diluted with filtered air to the desired concentration. Particles were continuously generated, and the exposure concentration was monitored and regulated during the exposure. Particle number, mass, and size distributions were monitored on both the inspiratory and expiratory sides of the subject. The subject inhaled from a mouthpiece and wore a nose clip. One-way valves (Hans-Rudolph, Inc., Kansas City, MO) prevented rebreathing of UFP. Air for the control exposures and for dilution of the particles was passed through charcoal and high-efficiency particle filters and was essentially free of particles (0–10 particles/cm3). The rationale and design of the exposure facility have been described in detail elsewhere (Chalupa et al. 2002).
Reactive hyperemia and nitric oxide metabolites
We measured RH of the forearm by venous occlusion plethysmography using the methodology reported by Delehanty et al. (1999). After subjects had a light breakfast, RH was measured supine in a quiet room, at the same time of day for each exposure, and before any other measurements such as phlebotomy and spirometry, because these studies may influence the measurements. To minimize dietary influence on plasma nitrate levels, subjects were placed on a low-nitrate diet on study days. A venous occlusion cuff was placed around the arm just above the elbow with the subject in the supine position, with the forearm at or above the level of the right atrium. A 1-min ischemic occlusion was performed for preconditioning. Three minutes later, a pediatric blood pressure cuff was positioned around the wrist to exclude wrist flow artifact, and a silicone strain gauge (Hokanson EC 5R; D.E. Hokanson, Inc., Bellevue, WA) was positioned so that it encircled the forearm at its widest diameter. With the wrist cuff inflated, the upper arm cuff was inflated to 40 mmHg and recordings of impedance were made for 5 sec. Five cycles of venous flow occlusion and 10 sec of cuff deflation were performed, and the results were averaged. Transient arterial occlusion was produced by inflating an upper arm cuff to 50 mmHg above systolic pressure for 5 min. Immediately after release of the occluding cuff, measurements of flow were obtained at 15-sec intervals for 3 min. Peak flow was defined as the maximum flow rate after release of the cuff. Minimal resistance was the mean arterial blood pressure divided by the peak flow. Total flow was the area under the 3-min flow curve.
We measured NO metabolites using the Sievers 270B NO analyzer (GE Analytical Instruments, Boulder, CO) equipped with a purge vessel. We measured the sum of plasma nitrite and nitrate by reducing nitrate to nitrite via nitrate reductase (Roche Diagnostics Corporation, Indianapolis, IN). The resulting nitrite was then further reduced to NO with potassium iodide in the purge vessel, and quantified by the NO analyzer. Injection of untreated plasma into the potassium iodide in the purge vessel measured plasma nitrite alone. We then calculated plasma nitrate concentrations by subtracting plasma nitrite from the sum of nitrite and nitrate to provide nitrate concentrations. Standard curves were generated using known concentrations of sodium nitrate and sodium nitrite (1.56–100 uM), and were used to verify the efficacy of the nitrate reductase. Data were acquired and analyzed using a Macintosh G4 computer with MacLab software (ADInstruments, Cupertino, CA). The lower limit of nitrate detection was 1.56 μM.
Data handling and statistical methods
We used a standard, two-period crossover design in which each subject received both particles and air (Pietropaoli et al. 2004b). The order of presentation was randomized separately for each sex, with half of the subjects receiving each of the two possible orders. There was a washout period of 3 weeks between the two exposures to avoid the possibility of carryover effects. Our approach is based on using mixed models for the analysis of crossover trials with repeated measurements within treatment (exposure) periods (Jones and Kenward 2003). Order of presentation and sex were treated as between-subject factors, and treatment, period, and time (when repeated measurements were made after each exposure) were considered within-subject factors. We performed the approximate t-tests and F-tests (Verbeke and Molenberghs 2000) comparing UFP versus filtered air exposure and evaluating significance of other factors (e.g., time). A p < 0.05 was considered statistically significant.
Results
Subjects and UFP characteristics
We studied 16 subjects, 8 male and 8 female, with mean (±SD) age 26.9 ± 6.5 years. The mean (± SD) UFP exposure parameters were as follows: target mass concentration of 50 μg/m3, with a measured mass concentration of 50.0 ± 3.9 μg/m3, particle number concentration 10.8 ± 1.7 ×106 particles/cm3, and particle count median diameter 27.9 ± 2.2 nm, with a GSD of 1.65 ± 0.02.
Heart rate, blood pressure, and oxygen saturation
There were no effects of UFP exposure on oxygen saturation, heart rate, or blood pressure (Table 1). The analysis of variance (ANOVA) revealed a significant interaction between sex and exposure for the heart-rate–systolic-blood-pressure product (HR ×BP), an indicator of cardiac work (p = 0.029). Males but not females showed a greater increase in HR ×BP immediately after exposure to UFP than to air (Figure 1). There were no other convincing sex-specific responses.
Table 1.
Vital signs before (baseline) and after exposure (mean ± SE).
Exposure | Time | Oxygen saturation (%) | HR (beats/min) | Systolic BP (mmHg) | HR × BP |
---|---|---|---|---|---|
Air | Baseline | 97.4 ± 0.2 | 77.0 ± 3.5 | 125.4 ± 3.1 | 9,618 ± 451 |
0 hr | 97.0 ± 0.2 | 94.8 ± 4.2 | 122.5 ± 3.0 | 11,494 ± 399 | |
3.5 hr | 97.4 ± 0.3 | 77.8 ± 2.8 | 116.4 ± 3.7 | 9,027 ± 391 | |
21 hr | 97.4 ± 0.2 | 78.6 ± 2.9 | 119.2 ± 2.7 | 9,315 ± 305 | |
45 hr | 97.6 ± 0.3 | 81.8 ± 2.6 | 120.8 ± 2.9 | 9,815 ± 257 | |
UFP | Baseline | 97.5 ± 0.3 | 76.4 ± 3.8 | 127.9 ± 3.3 | 9,770 ± 537 |
0 hr | 97.0 ± 0.2 | 96.8 ± 4.8 | 125.7 ± 4.2 | 12,108 ± 613 | |
3.5 hr | 97.4 ± 0.3 | 81.1 ± 2.9 | 119.6 ± 3.1 | 9,666 ± 365 | |
21 hr | 97.3 ± 0.3 | 79.9 ± 2.7 | 120.4 ± 4.4 | 9,569 ± 413 | |
45 hr | 97.6 ± 0.3 | 79.1 ± 2.7 | 121.6 ± 3.6 | 9,565 ± 342 |
Figure 1.
Change in the product of HR ×BP (mmHg) in females (A) and males (B). Data are mean ± SE. UFP × sex, p = 0.029.
Forearm blood flow and reactive hyperemia
Figure 2 shows the forearm blood flow after ischemia at 0 and 3.5 hr after exposure to air and UFP. Time 0 represents the peak flow measured on release of the occluding cuff. At 3.5 hr after exposure (Figure 2B), a small reduction in peak flow was seen with UFP relative to air exposure, with no differences for the subsequent measurements. Figure 3 shows the peak flow and minimal resistance as changes from preexposure baseline at all time points. Peak flow increased, and minimal resistance decreased, 3.5 hr after exposure to air. This increase in peak flow was not seen with UFP exposure. The difference in peak flow at this time point was significant by crossover paired t-test [change from preexposure baseline, air: 9.31 ± 3.41; UFP: 1.09 ± 2.55 mL/min/100 mL; p = 0.034 (Figure 3A)] but there was no difference across the entire 48-hr measurement period by ANOVA (exposure–time interaction, p = 0.143). The difference in minimal resistance was significant by ANOVA [change from preexposure baseline, air: −0.48 ± 0.21; UFP: 0.07 ± 0.19 mmHg/mL/min; exposure–time interaction, p = 0.024 (Figure 3B)]. There was no UFP effect on baseline flow, baseline resistance, or total flow.
Figure 2.
Forearm blood flow after ischemia, 0 hr (A) and 3.5 hr (B) after exposure. Data are mean ± SE. Arrows indicate peak flow, which increased 3.5 hr after air but not UFP exposure. There were no significant differences between air and UFP exposure for total flow (area under the curve).
Figure 3.
Changes from preexposure baseline in peak flow (A) and minimal resistance (B) at all time points. Data are mean ± SE. Peak flow increased, and minimal resistance decreased, 3.5 hr after air but not UFP exposure. The difference in peak flow 3.5 hr after exposure was significant by paired t-test (p = 0.034) but not by ANOVA (p = 0.143). The difference in minimal resistance was significant by ANOVA (UFP × time, p = 0.024).
Nitrite and nitrate
Venous nitrate levels decreased after UFP exposure, and were significantly lower than after air exposure [UFP: 29.61 ± 3.41 μM; air: 32.52 ± 2.79 μM 21 hr after exposure, p = 0.038 by ANOVA (Figure 4B)]. Venous nitrite levels also decreased, but the changes were not statistically significant (p = 0.286). The changes in peak RH 3.5 hr after UFP but not air exposure were significantly correlated with the changes in plasma nitrate levels immediately after exposure (Figure 5), but not with changes in nitrate levels at subsequent measurements. There were no significant relationships between changes in RH and BP ×HR.
Figure 4.
Venous plasma concentrations of nitrite (A) and nitrate (B). Data are mean ± SE. Both nitrite and nitrate levels decreased after UFP exposure; the changes in nitrate were significant by ANOVA (p = 0.038).
Figure 5.
Relationship between peak forearm blood flow (change from pre-UFP exposure to 3.5 hr after exposure) and plasma nitrate concentrations (change from pre-UFP exposure to 0 hr after exposure). (A) UFP (r = 0.69, p = 0.003). (B) Air (r = 0.30, p = 0.26). There was no significant relationship between forearm blood flow and nitrate levels after air exposure.
Discussion
These are the first human experimental studies examining the systemic vascular effects of breathing an aerosol of pure UFP. The particles consisted of elemental carbon, without organic compounds or metals that have been implicated in PM effects. We tested the hypothesis that inhalation of carbon UFP impairs forearm RH in healthy nonsmokers. Peak hyperemic flow during RH increased, and minimal vascular resistance decreased, 3.5 hr after air exposure with intermittent exercise. Breathing UFP blunted these changes (Figure 2). There was no significant effect of UFP on total forearm flow during RH. UFP exposures significantly reduced venous nitrate concentrations.
We also found an increase in HR ×BP in males after UFP exposure [exposure–sex interaction, p = 0.03 (Figure 1)]. Hormonal influences may have protected the females from this effect. HR ×BP, or the rate–pressure product, is a well-recognized noninvasive estimate of myocardial work, although the cardiac pressure–volume loop is the gold standard for assessing contractility. Changes in HR ×BP predict myocardial oxygen consumption during exercise (Gobel et al. 1978), and may reflect changes in cardiac function or peripheral vascular tone. Not all changes in cardiac oxygen consumption are reflected by HR ×BP. However, increases in HR ×BP would be expected to worsen myocardial ischemia in patients with critical coronary artery disease. Some studies have observed increases in blood pressure associated with exposure to ambient PM (Ibald-Mulli et al. 2001; Urch et al. 2005), but other studies have not (Ibald-Mulli et al. 2004).
Endothelial dysfunction is an initial step in the development of atherosclerosis (Quyyumi 1998), and an important factor in the development of hypertension and heart failure (Corretti et al. 2002). Impaired endothelium-dependent vascular reactivity has been linked epidemiologically to unstable angina, myocardial infarction, and cardiovascular deaths, even in the absence of obstructive coronary artery disease (Halcox et al. 2002). Forearm venous plethysmography is a well-established method for assessing systemic vascular function, with defined accuracy and reproducibility (Joannides et al. 2006). The increase in flow after infusion of acetylcholine is considered by many to be the “gold standard” for measuring endothelial function, and is predictive of future cardiovascular events (Heitzer et al. 2001; Perticone et al. 2001). In this study, we chose not to perform acetylcholine infusion during RH to avoid the risk and discomfort of arterial catheterization, and to avoid possible effects on subsequent measurements of RH and plasma NO products. Forearm blood flow during RH correlates well with vasodilation during maximal acetylcholine infusion (Higashi et al. 2001). RH is not primarily endothelium-dependent (Tagawa et al. 1994), but initiates upstream flow-mediated dilatation, which is endothelium-dependent.
The increase in peak flow during RH 3.5 hr after air exposure may be a response to the intermittent exercise during exposure. In a recent study of 12 sedentary subjects (Bousquet-Santos et al. 2005), forearm blood flow during RH increased 10 and 60 min after 10 min of maximal exercise, and returned to baseline levels 120 min after exercise. Our subjects required some degree of fitness to perform 2 hr of intermittent exercise; it is possible that the increased fitness level of our subjects, together with the prolonged intermittent exercise, caused a more delayed and persistent increase in peak flow. It is well established that chronic exercise improves endothelial function (Clarkson et al. 1999; Rakobowchuk et al. 2005). Diurnal variation could also be responsible for the increase at 3.5 hr after exposure, because this measurement was performed in the afternoon. In contrast, all other measurements were performed earlier in the day. Artifact introduced by order of exposure or participant bias was prevented by the double-blind, randomized, crossover study design. Although the reason for the delayed increase in peak flow after air exposure is not entirely clear, exposure to UFP appeared to block the effect.
We measured venous concentrations of nitrate and nitrite as products of NO metabolism. Nitrate levels decreased significantly after UFP, relative to air exposure. Reductions in venous nitrate levels immediately after UFP exposure correlated significantly with the reductions in peak forearm blood flow 3.5 hr after exposure (Figure 5), although changes in nitrate levels at other times did not correlate with forearm flow.
NO, produced by endothelial cells from l-arginine via NO synthase, mediates vasodilation in both pulmonary and systemic vascular beds (Ikeda et al. 1995; Joannides et al. 1995). The generation of NO is driven by an influx of calcium via calcium-activated potassium channels, which activate endothelial NO synthase (Cooke et al. 1991), and by calcium-independent mechanisms associated with blood flow shear stress (Fleming et al. 1998). However, RH is governed by other factors in addition to NO; infusion of an NO synthase inhibitor into the forearm circulation only partially blocks RH. Furthermore, the peak flow response during RH does not appear to be mediated by NO, and may represent a response to tissue hypoxia, adenosine accumulation, vasodilating prostaglandins, myogenic factors, or endothelium-dependent hyperpolarizing factor (Tagawa et al. 1994). Because NO does not appear to be important in regulating peak flow during RH, it seems unlikely that the UFP effects on peak flow observed in our study are directly related to UFP effects on NO.
Inhalation of UFP may deplete NO by delivering reactive chemical species to the vascular endothelium. When compared on a particle mass basis, UFP have greater oxidant capacity than larger particles (Brown et al. 2001; Li et al. 2003), possibly related to their high surface area and potential to adsorb reactive chemical species from the air. Furthermore, UFP can cross cell membranes via diffusional mechanisms, entering cell nuclei and mitochondria (Geiser et al. 2005). UFP and their burden of reactive chemical species may enter the pulmonary vascular space and then the systemic circulation, although the degree to which this occurs in humans is unclear (Mills et al. 2006; Nemmar et al. 2002). Reactive oxygen species formed as a result of particle exposure may react with NO, forming peroxynitrite, in turn perpetuating the oxidant injury that contributes to endothelial dysfunction and atherosclerosis.
Other mechanisms may be involved, including lung inflammatory responses with secondary vascular effects. However, our previous studies have found no evidence for airway inflammation, as measured by sputum induction and exhaled NO, in response to carbon UFP exposure (Frampton et al. 2004; Pietropaoli et al. 2004b, 2004c). In a recent study, recovery of inflammatory cells in bronchoalveolar lavage fluid did not increase 18 hr after exposure to concentrated ambient UFP (Samet et al. 2007). Thus airway inflammation is unlikely to explain the vascular effects of UFP exposure.
Epidemiologic, panel, and other clinical studies also support the hypothesis that exposure to particulate matter, including UFP, alters endothelial function. In a large panel study of people with diabetes (O’Neill et al. 2005), several different measures of PM exposure were significantly associated with reductions in vascular reactivity. Recently, Künzli et al. (2005) found a significant relationship between long-term PM exposure and a marker of atherosclerosis, the thickness of the carotid artery endothelium measure by ultrasound. Short-term inhalation of concentrated ambient particles plus ozone caused systemic vasoconstriction in resting human subjects (Brook et al. 2002), and the effect appeared to be most strongly related to the organic and elemental carbon content of the particles (Urch et al. 2004). Inhalation of diesel exhaust for 1 hr, with intermittent exercise, attenuated the forearm vasodilation response to infusion of both acetylcholine and nitro-prusside, but not verapamil, in human subjects, both 2 and 6 hr after exposure (Mills et al. 2005). This suggests that diesel exhaust, which is rich in UFP and elemental carbon, impairs both endothelium-dependent and -independent vasodilation. However, the diesel studies used PM concentrations approximately 6-fold higher (∼300 μg/m3) than our study (50 μg/m3), and included diesel exhaust gases, particularly nitrogen dioxide and CO.
In vitro and in vivo animal studies also provide evidence of a relationship between particle inhalation and endothelial dysfunction. For example, Batalha et al. (2002) reported that concentrated ambient particles induced vasoconstriction of small pulmonary arteries in rats. Instillation of residual oil fly ash increased pulmonary artery pressure in rats, via mechanisms involving epidermal growth factor (Huang et al. 2002). Urban particles caused constriction of rat pulmonary artery rings, via the angiotensin-I receptor (Li et al. 2005). Furthermore, extracts of particles from motorcycle exhaust enhanced vasoconstriction in vitro, via pathways involving reactive oxygen species and calcium flux (Tzeng et al. 2003).
We have shown previously that exposure to carbon UFP with intermittent exercise causes a significant decrease in the pulmonary diffusion capacity for CO (Pietropaoli et al. 2004b), and reduces peripheral blood leukocyte expression of some adhesion molecules (Frampton et al. 2006). Both of these effects may result from pulmonary vasoconstriction. Effects on peripheral blood leukocytes were generally maximal at 3.5 hr after exposure—similar to the timing of effects on RH in the present study. Taken together, our data suggest that inhalation of carbon UFP with intermittent exercise alters both pulmonary and systemic vascular function.
There are limitations to this study. Effects of breathing laboratory-generated carbon UFP may not be representative of ambient UFP, although ambient UFP contain elemental carbon. The mass concentration of particles used in this study (50 μg/m3) and the particle number concentrations (∼107/cm3) exceed those encountered in most outdoor environments, although particle numbers on major highways can reach peaks of 107 particles/cm3 (Kittelson et al. 2004). The subjects were healthy lifetime nonsmokers, without significant cardiovascular disease, and do not represent those most susceptible to the cardiovascular effects of PM exposure. Exposures were by mouthpiece, which bypasses nasal clearance mechanisms and alters breathing patterns. However, UFP in the 20- to 40-nm size range are predicted to have relatively low nasal deposition (Daigle et al. 2003), so oral–nasal breathing would not be expected to substantially reduce UFP pulmonary deposition in these studies. Finally, our study, like most human controlled exposure studies, included a relatively small number of subjects, which limited the statistical power. However, the observation of effects on both vascular function and NO metabolism provide biologic plausibility to our findings.
The observed effects are small and not clinically important for healthy subjects. However, for patients with critical coronary artery disease, small changes in vascular responsiveness combined with increased myocardial oxygen demands could worsen ischemia and precipitate adverse events. For example, in a recent clinical study (Mills et al. 2007), exposures to diluted diesel exhaust increased the myocardial ischemic burden in men with stable coronary artery disease and previous myocardial infarction. Based on our initial findings in healthy volunteers, it seems highly plausible that inhalation of UFP would present risks similar to that for diesel exhaust in patients with coronary artery disease. Taken together with other human and animal studies of PM exposure, there is increasingly compelling evidence that inhalation of PM impairs systemic endothelial function. Our findings support a role for UFP in the vascular effects of PM exposure.
Conclusion
In comparison with air exposure, inhalation of 50 μg/m3 carbon UFP reduced peak hyperemic forearm blood flow, increased minimal vascular resistance, and reduced plasma nitrate concentrations. These findings support the hypothesis that inhalation of UFP impairs systemic vascular function and reduces NO bioavailability. These effects represent potential mechanisms linking particle exposure and adverse cardiovascular effects.
Footnotes
This research was supported by U.S. Environmental Protection Agency Assistance Agreement RD 832415–1, grants RO1 ES011853, RO1 ES013394, RR00044, and ES01247 from the National Institutes of Health, the Electric Power Research Institute, and grant 4913-ERTER-ES-99 from the New York State Energy Research and Development Authority.
References
- Batalha JR, Saldiva PH, Clarke RW, Coull BA, Stearns RC, Lawrence J, et al. Concentrated ambient air particles induce vasoconstriction of small pulmonary arteries in rats. Environ Health Perspect. 2002;110:1191–1197. doi: 10.1289/ehp.021101191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bousquet-Santos K, Soares PP, Nobrega AC. Subacute effects of a maximal exercise bout on endothelium-mediated vasodilation in healthy subjects. Braz J Med Biol Res. 2005;38(4):621–627. doi: 10.1590/s0100-879x2005000400017. [DOI] [PubMed] [Google Scholar]
- Bremner SA, Anderson HR, Atkinson RW, McMichael AJ, Strachan DP, Bland JM, et al. Short-term associations between outdoor air pollution and mortality in London 1992–4. Occup Environ Med. 1999;56(4):237–244. doi: 10.1136/oem.56.4.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation. 2002;105:1534–1536. doi: 10.1161/01.cir.0000013838.94747.64. [DOI] [PubMed] [Google Scholar]
- Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol. 2001;175:191–199. doi: 10.1006/taap.2001.9240. [DOI] [PubMed] [Google Scholar]
- Burnett RT, Smith-Doiron M, Stieb D, Cakmak S, Brook JR. Effects of particulate and gaseous air pollution on cardiorespiratory hospitalizations. Arch Environ Health. 1999;54(2):130–139. doi: 10.1080/00039899909602248. [DOI] [PubMed] [Google Scholar]
- Chalupa DC, Morrow PE, Oberdörster G, Utell MJ, Frampton MW. Ultrafine particle deposition in subjects with asthma. Environ Health Perspect. 2004;112:879–882. doi: 10.1289/ehp.6851. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chalupa DF, Gibb FR, Morrow PE, Oberdörster G, Riesenfeld E, Gelein R, et al. A facility for controlled human exposures to ultrafine particles. In: Heinrich U, Mohr U, editors. Crucial Issues in Inhalation Research: Mechanistic, Clinical and Epidemiologic. Washington, DC: ILSI Press; 2002. pp. 241–253. [Google Scholar]
- Clarkson P, Montgomery HE, Mullen MJ, Donald AE, Powe AJ, Bull T, et al. Exercise training enhances endothelial function in young men. J Am Coll Cardiol. 1999;33(5):1379–1385. doi: 10.1016/s0735-1097(99)00036-4. [DOI] [PubMed] [Google Scholar]
- Cooke JP, Rossitch E, Jr, Andon NA, Loscalzo J, Dzau VJ. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest. 1991;88(5):1663–1671. doi: 10.1172/JCI115481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol. 2002;39:257–265. doi: 10.1016/s0735-1097(01)01746-6. [DOI] [PubMed] [Google Scholar]
- Daigle CC, Chalupa DC, Gibb FR, Morrow PE, Oberdörster G, Utell MJ, et al. Ultrafine particle deposition in humans during rest and exercise. Inhal Toxicol. 2003;15:539–552. doi: 10.1080/08958370304468. [DOI] [PubMed] [Google Scholar]
- Delehanty J, Liang C-S, Odorisi ML. Effects of dobutamine on ischemic vasodilation of the forearm in patients with severe congestive heart failure. J Card Fail. 1999;5:25–30. doi: 10.1016/s1071-9164(99)90021-0. [DOI] [PubMed] [Google Scholar]
- Fleming I, Bauersachs J, Fisslthaler B, Busse R. Ca2+-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress. Circ Res. 1998;82(6):686–695. doi: 10.1161/01.res.82.6.686. [DOI] [PubMed] [Google Scholar]
- Frampton MW, Stewart JC, Oberdörster G, Morrow PE, Chalupa D, Pietropaoli AP, et al. Inhalation of carbon utrafine particles alters blood leukocyte expression of adhesion molecules in humans. Environ Health Perspect. 2006;114:51–58. doi: 10.1289/ehp.7962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Frampton MW, Utell MJ, Zareba W, Oberdörster G, Cox C, Huang L-S, et al. Effects of Exposure to Ultrafine Carbon Particles in Healthy Subjects and Subjects with Asthma. Health Effects Institute Research Report No. 126. Boston, MA: Health Effects Institute; 2004. [PubMed] [Google Scholar]
- Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schulz H, et al. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect. 2005;113:1555–1560. doi: 10.1289/ehp.8006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gobel FL, Norstrom LA, Nelson RR, Jorgensen CR, Wang Y. The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation. 1978;57(3):549–556. doi: 10.1161/01.cir.57.3.549. [DOI] [PubMed] [Google Scholar]
- Gold DR, Litonjua A, Schwartz J, Lovett E, Larson A, Nearing B, et al. Ambient pollution and heart rate variability. Circulation. 2000;101:1267–1273. doi: 10.1161/01.cir.101.11.1267. [DOI] [PubMed] [Google Scholar]
- Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106(6):653–658. doi: 10.1161/01.cir.0000025404.78001.d8. [DOI] [PubMed] [Google Scholar]
- Heitzer T, Schlinzig T, Krohn K. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104:2673–2678. doi: 10.1161/hc4601.099485. [DOI] [PubMed] [Google Scholar]
- Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Kajiyama G, Oshima T. A noninvasive measurement of reactive hyperemia that can be used to assess resistance artery endothelial function in humans. Am J Cardiol. 2001;87(1):121. doi: 10.1016/s0002-9149(00)01288-1. [DOI] [PubMed] [Google Scholar]
- Huang YC, Wu W, Ghio AJ, Carter JD, Silbajoris R, Devlin RB, et al. Activation of EGF receptors mediates pulmonary vasoconstriction induced by residual oil fly ash. Exp Lung Res. 2002;28(1):19–38. doi: 10.1080/019021402753355517. [DOI] [PubMed] [Google Scholar]
- Ibald-Mulli A, Stieber J, Wichmann HE, Koenig W, Peters A. Effects of air pollution on blood pressure: a population-based approach. Am J Public Health. 2001;91(4):571–577. doi: 10.2105/ajph.91.4.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ibald-Mulli A, Timonen KL, Peters A, Heinrich J, Wölke G, Lanki T, et al. Effects of particulate air pollution on blood pressure and heart rate in subjects with cardiovascular disease: a multicenter approach. Environ Health Perspect. 2004;112:369–377. doi: 10.1289/ehp.6523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ikeda M, Suzuki M, Watarai K, Sagai M, Tomita T. Impairment of endothelium-dependent relaxation by diesel exhaust particles in rat thoracic aorta. Jpn J Pharmacol. 1995;68(2):183–189. doi: 10.1254/jjp.68.183. [DOI] [PubMed] [Google Scholar]
- Joannides R, Bellien J, Thuillez C. Clinical methods for the evaluation of endothelial function—a focus on resistance arteries. Fundam Clin Pharmacol. 2006;20(3):311–320. doi: 10.1111/j.1472-8206.2006.00406.x. [DOI] [PubMed] [Google Scholar]
- Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91(5):1314–1319. doi: 10.1161/01.cir.91.5.1314. [DOI] [PubMed] [Google Scholar]
- Jones B, Kenward MG. Design and Analysis of Crossover Trials. 2. New York: Chapman and Hall; 2003. [Google Scholar]
- Kittelson DB, Watts WF, Johnson JP, Remerowki ML, Ische EE, Oberdörster G, et al. On-road exposure to highway aerosols. 1. Aerosol and gas measurements. Inhal Toxicol. 2004;16(suppl 1):31–39. doi: 10.1080/08958370490443024. [DOI] [PubMed] [Google Scholar]
- Künzli N, Jerrett M, Mack WJ, Beckerman B, LaBree L, Gilliland F, et al. Ambient air pollution and atherosclerosis in Los Angeles. Environ Health Perspect. 2005;113:201–206. doi: 10.1289/ehp.7523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, et al. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect. 2003;111:455–460. doi: 10.1289/ehp.6000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li Z, Carter JD, Dailey LA, Huang Y-CT. Pollutant particles produce vasoconstriction and enhance MAPK signaling via angiotensin type I receptor. Environ Health Perspect. 2005;113:1009–1014. doi: 10.1289/ehp.7736. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McDonald JD, Powell QH, Bowen LE, Mauderly JL. Organic carbon content of aerosols produced from a Palas carbon generation system. Toxicologist. 2001;60:430. [Google Scholar]
- Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, et al. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med. 2007;356(5):447–458. doi: 10.1056/NEJMoa054409. [DOI] [PubMed] [Google Scholar]
- Mills NL, Amin N, Robinson SD, Anand A, Davies J, Patel D, et al. Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am J Respir Crit Care Med. 2006;173(4):426–431. doi: 10.1164/rccm.200506-865OC. [DOI] [PubMed] [Google Scholar]
- Mills NL, Törnqvist H, Gonzalez MC, Vink E, Robinson SD, Söderberg S, et al. Ischemic and thrombotic effects of dilute diesel exhaust inhalation in men with coronary heart disease. N Engl J Med. 2007;357:1075–1082. doi: 10.1056/NEJMoa066314. [DOI] [PubMed] [Google Scholar]
- Mills NL, Tornqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, et al. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation. 2005;112(25):3930–3936. doi: 10.1161/CIRCULATIONAHA.105.588962. [DOI] [PubMed] [Google Scholar]
- Nemmar A, Hoet PH, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, et al. Passage of inhaled particles into the blood circulation in humans. Circulation. 2002;105(4):411–414. doi: 10.1161/hc0402.104118. [DOI] [PubMed] [Google Scholar]
- Oberdörster G, Gelein RM, Ferin J, Weiss B. Association of particulate air pollution and acute mortality: involvement of ultrafine particles? Inhal Toxicol. 1995;7:111–124. doi: 10.3109/08958379509014275. [DOI] [PubMed] [Google Scholar]
- O’Neill MS, Veves A, Zanobetti A, Sarnat JA, Gold DR, Economides PA, et al. Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation. 2005;111(22):2913–2920. doi: 10.1161/CIRCULATIONAHA.104.517110. [DOI] [PubMed] [Google Scholar]
- Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104(2):191–196. doi: 10.1161/01.cir.104.2.191. [DOI] [PubMed] [Google Scholar]
- Peters A, Dockery DW, Muller JE, Mittleman MA. Increased particulate air pollution and the triggering of myocardial infarction. Circulation. 2001;103:2810–2815. doi: 10.1161/01.cir.103.23.2810. [DOI] [PubMed] [Google Scholar]
- Peters A, Liu E, Verrier RL, Schwartz J, Gold DR, Mittleman M, et al. Air pollution and incidence of cardiac arrhythmia. Epidemiology. 2000;11:11–17. doi: 10.1097/00001648-200001000-00005. [DOI] [PubMed] [Google Scholar]
- Peters A, von Klot S, Heier M, Trentinaglia I, Hörmann A, Wichmann HE, et al. Exposure to traffic and the onset of myocardial infarction. N Engl J Med. 2004;351:1721–1730. doi: 10.1056/NEJMoa040203. [DOI] [PubMed] [Google Scholar]
- Pietropaoli AP, Delehanty JM, Perkins PT, Utell MJ, Oberdörster G, Hyde RW, et al. Venous nitrate, nitrite, and forearm blood flow after carbon ultrafine particle exposure in healthy human subjects. Am J Respir Crit Care Med. 2004a;169:A883. [Google Scholar]
- Pietropaoli AP, Frampton MW, Hyde RW, Morrow PE, Oberdörster G, Cox C, et al. Pulmonary function, diffusing capacity and inflammation in healthy and asthmatic subjects exposed to ultrafine particles. Inhal Toxicol. 2004b;16(suppl 1):59–72. doi: 10.1080/08958370490443079. [DOI] [PubMed] [Google Scholar]
- Pietropaoli AP, Frampton MW, Oberdörster G, Cox C, Huang L-S, Marder V, et al. Blood markers of coagulation and inflammation in healthy human subjects exposed to carbon ultrafine particles. In: Heinrich U, editor. Effects of Air Contaminants on the Respiratory Tract: Interpretations from Molecular to Meta Analysis. Stuttgart, Germany: INIS Monographs, Fraunhofer IRB Verlag; 2004c. pp. 181–194. [Google Scholar]
- Pope CA, III, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002;287(9):1132–1141. doi: 10.1001/jama.287.9.1132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pope CA, III, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, et al. Cardiovascular mortality and long-term exposure to particulate air pollution. Epidemiological evidence of general pathophysiological pathways of disease. Circulation. 2004;109:71–77. doi: 10.1161/01.CIR.0000108927.80044.7F. [DOI] [PubMed] [Google Scholar]
- Pope CA, III, Verrier RL, Lovett EG, Larson AC, Raizenne ME, Kanner RE, et al. Heart rate variability associated with particulate air pollution. Am Heart J. 1999;138(5 Pt 1):890–899. doi: 10.1016/s0002-8703(99)70014-1. [DOI] [PubMed] [Google Scholar]
- Quyyumi AA. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med. 1998;105(1A):32S–39S. doi: 10.1016/s0002-9343(98)00209-5. [DOI] [PubMed] [Google Scholar]
- Rakobowchuk M, McGowan CL, de Groot PC, Hartman JW, Phillips SM, MacDonald MJ. Endothelial function of young healthy males following whole body resistance training. J Appl Physiol. 2005;98(6):2185–2190. doi: 10.1152/japplphysiol.01290.2004. [DOI] [PubMed] [Google Scholar]
- Rückerl R, Ibald-Mulli A, Koenig W, Henneberger A, Woelke G, Cyrys J, et al. Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med. 2006;173:432–441. doi: 10.1164/rccm.200507-1123OC. [DOI] [PubMed] [Google Scholar]
- Samet JM, Graff D, Bernsten J, Ghio AJ, Huang Y-CT, Devlin RB. A comparison of studies on the effects of controlled exposure to fine, coarse and ultrafine ambient particulate matter from a single location. Inhal Toxicol. 2007;19(suppl 1):29–32. doi: 10.1080/08958370701492706. [DOI] [PubMed] [Google Scholar]
- Stearns RC, Murthy GGK, Skornik W, Hatch V, Katler M, Godleski JJ. Detection of ultrafine copper oxide particles in the lungs of hamsters by electron spectroscopic imaging. In: Jouffrey B, Colliex C, editors. Proceedings of ICEM 13-PARIS. Paris: Les Editions de Physique; 1994. pp. 763–764. [Google Scholar]
- Tagawa T, Imaizumi T, Endo T, Shiramoto M, Harasawa Y, Takeshita A. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation. 1994;90(5):2285–2290. doi: 10.1161/01.cir.90.5.2285. [DOI] [PubMed] [Google Scholar]
- Tzeng HP, Yang RS, Ueng TH, Lin-Shiau SY, Liu SH. Motorcycle exhaust particulates enhance vasoconstriction in organ culture of rat aortas and involve reactive oxygen species. Toxicol Sci. 2003;75(1):66–73. doi: 10.1093/toxsci/kfg164. [DOI] [PubMed] [Google Scholar]
- Urch B, Brook JR, Wasserstein D, Brook RD, Rajagopalan S, Corey P, et al. Relative contributions of PM2.5 chemical constituents to acute arterial vasoconstriction in humans. Inhal Toxicol. 2004;16:345–352. doi: 10.1080/08958370490439489. [DOI] [PubMed] [Google Scholar]
- Urch B, Silverman F, Corey P, Brook JR, Lukic KZ, Rajagopalan S, et al. Acute blood pressure responses in healthy adults during controlled air pollution exposures. Environ Health Perspect. 2005;113:1052–1055. doi: 10.1289/ehp.7785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. Berlin: Springer-Verlag; 2000. [Google Scholar]